stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Free cash flow margin
DENTSPLY SIRONA Inc.'s free cash flow margin over the twelve months to 30 September 2026 was 7.61%, up 4.8 percentage points from fiscal 2025 (2.83%). Over the past ten years it has ranged from 2.83% (fiscal 2025) to 16.8% (fiscal 2020) — the current reading is the lowest in ten years. That is above the Medical Instruments & Supplies industry median of 2.36% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 2.83% | (4.58) |
| FY2024 | 7.41% | 1.66 |
| FY2023 | 5.75% | (3.63) |
| FY2022 | 9.38% | (2.79) |
| FY2021 | 12.2% | (4.66) |
| FY2020 | 16.8% | 4.00 |
| FY2019 | 12.8% | 4.78 |
| FY2018 | 8.05% | (3.43) |
| FY2017 | 11.5% | (0.33) |
| FY2016 | 11.8% | (4.11) |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| LMAT LeMaitre Vascular, Inc. compare | 24.9% |
| ATRC AtriCure, Inc. compare | 8.98% |
| XRAY DENTSPLY SIRONA Inc. | 7.61% |
| STAA STAAR Surgical Company compare | 5.44% |
| WRBY Warby Parker Inc. compare | 2.28% |
| AZTA Azenta, Inc. compare | 1.61% |
| STVN Stevanato Group S.p.A. compare | −0.61% |
| KMTS Kestra Medical Technologies, Ltd. compare | −115.3% |
| PLSE Pulse Biosciences, Inc compare | −14,462.5% |
| Medical Instruments & Supplies industry median | 2.36% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement